United Healthcare's Baby Blocks app seeks to become all-in-one hub for expectant moms and their babies.
Tecfidera gets label change; Amgen and AstraZeneca report psoriasis Phase-III antibody results; JAMA study reinforces statin guidelines.
Encouraging competitors to take an artistic approach to "Breathless Moments," the competition is a first for Bayer, which is already working on next year's effort.
The scientist is also banned from receiving federal funding.
The German firm positions to focus on pharma pipeline and animal health.
Onexton is a first-and-only drug combination for treating acne.
AstraZeneca and Ranbaxy pay-for-delay case marches on; FDA extends Novartis multiple myeloma Priority Review timeline; Endo pays $25 for testosterone nasal gel.
The Center for Drug Evaluation and Research's director says there is a need for new opioids and cuts off dosing comparisons between extended-release and immediate-release opioids.
The north-of-the-border solution comes amid climbing heroin abuse in the US.
The reason: coordination and effectiveness.
The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.